← Evidence map

ArticleBlood advances2026

Rituximab maintenance after first-line rituximab-bendamustine.

Christian Brieghel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42126259